Ptc Therapeutics (PTCT) Raw Materials (2019 - 2026)

Ptc Therapeutics' Raw Materials history runs 8 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• In Q1 2026, Raw Materials fell 23.6% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (down 23.6% YoY), while the FY2025 annual figure was $2.3 million, down 9.73% from the prior year.
• Raw Materials was $1.6 million for Q1 2026 at Ptc Therapeutics, down from $2.3 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $2.7 million in Q3 2024 to a low of $907000.0 in Q3 2023.
• Historically, Raw Materials has averaged $1.6 million across 5 years, with a median of $1.4 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Raw Materials decreased 26.92% in 2023, then soared 201.87% in 2024.
• A 5-year view of Raw Materials shows it stood at $1.1 million in 2022, then decreased by 11.69% to $952000.0 in 2023, then soared by 166.6% to $2.5 million in 2024, then decreased by 9.73% to $2.3 million in 2025, then declined by 29.9% to $1.6 million in 2026.
• The last three Raw Materials figures came in at $1.6 million (Q1 2026), $2.3 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.